Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isochromene Derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110204533B reveals a novel silver-catalyzed route for 4-(isochromen-1-yl)isoquinoline derivatives, offering mild conditions and high yields for pharmaceutical intermediate manufacturing.